scholarly article | Q13442814 |
P2093 | author name string | Je-Jung Lee | |
Jung-Joon Min | |||
Yeongjin Hong | |||
Robert A Harris | |||
Daejin Lim | |||
Hyon E Choy | |||
Geun-Joong Kim | |||
Misun Yun | |||
Jae Ho Jeong | |||
Kwangsoo Kim | |||
Hyung-Ju Lim | |||
So-Ra Shin | |||
P2860 | cites work | Salmonella and cancer: from pathogens to therapeutics | Q27015676 |
Perk is essential for translational regulation and cell survival during the unfolded protein response | Q28140062 | ||
Use of ?-asparaginase in childhood ALL | Q29041017 | ||
Bidirectional transport of amino acids regulates mTOR and autophagy | Q29614476 | ||
Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium | Q33756746 | ||
Tumor-targeted Salmonella. Highly selective delivery vectors | Q33918207 | ||
A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy | Q34315760 | ||
Asparagine synthetase: regulation by cell stress and involvement in tumor biology | Q34327474 | ||
Initiation factor eIF2 alpha phosphorylation in stress responses and apoptosis. | Q34383407 | ||
Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion | Q34473984 | ||
A novel balanced-lethal host-vector system based on glmS. | Q34654013 | ||
Analysis of the Escherichia coli gene encoding L-asparaginase II, ansB, and its regulation by cyclic AMP receptor and FNR proteins. | Q35001857 | ||
Tracing ancestors and relatives of Escherichia coli B, and the derivation of B strains REL606 and BL21(DE3). | Q35004007 | ||
Targeting tumors with salmonella Typhimurium- potential for therapy | Q35169604 | ||
Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine. | Q36933370 | ||
Engineering the perfect (bacterial) cancer therapy | Q37131536 | ||
A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase | Q37241386 | ||
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. | Q37311260 | ||
Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent | Q37316867 | ||
Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. | Q37424066 | ||
Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium | Q37451801 | ||
A phase II clinical trial of polyethylene glycol-conjugated L-asparaginase in patients with advanced ovarian cancer: Early closure for safety | Q37562460 | ||
Bacteriolytic therapy can generate a potent immune response against experimental tumors | Q37585498 | ||
Asparaginase revisited | Q37833637 | ||
Methods for the development of tumor-targeting bacteria | Q38221907 | ||
Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli | Q38503600 | ||
Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer | Q39760012 | ||
L-Asparaginase: A Review | Q39931950 | ||
Selective apoptosis of natural killer-cell tumours by l-asparaginase. | Q40374756 | ||
ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. | Q40552048 | ||
The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. | Q41465002 | ||
L-asparaginase kills lymphoma cells by apoptosis | Q41579847 | ||
Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors | Q45882843 | ||
Uncharged tRNA and sensing of amino acid deficiency in mammalian piriform cortex. | Q46386380 | ||
Tumor-targeted Salmonella as a novel anticancer vector | Q50133173 | ||
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. | Q50904345 | ||
L-asparaginase | Q69899631 | ||
Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase | Q73879722 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | Salmonella Typhimurium | Q166491 |
P304 | page(s) | 15007 | |
P577 | publication date | 2015-06-10 | |
P1433 | published in | Molecular therapy oncolytics | Q27726823 |
P1476 | title | L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors | |
P478 | volume | 2 |
Q50317370 | Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella |
Q89992810 | Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy |
Q88493610 | Metabolic reprogramming of the tumor microenvironment by p62 and its partners |
Q104280671 | Tweak to Treat: Reprograming Bacteria for Cancer Treatment |
Search more.